Arrowstreet Capital Limited Partnership Trims Stock Holdings in CVS Health Co. (NYSE:CVS)

Arrowstreet Capital Limited Partnership lowered its stake in shares of CVS Health Co. ( NYSE:CVS – Free Report ) by 94.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).

The institutional investor owned 183,145 shares of the pharmacy operator’s stock after selling 2,867,351 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in CVS Health were worth $8,221,000 at the end of the most recent reporting period. A number of other large investors have also recently made changes to their positions in CVS.



EagleClaw Capital Managment LLC boosted its stake in CVS Health by 3.4% in the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator’s stock worth $275,000 after purchasing an additional 200 shares during the period.

Manchester Capital Management LLC lifted its holdings in shares of CVS Health by 4.8% in the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock worth $200,000 after buying an additional 204 shares in the last quarter.

Angeles Investment Advisors LLC boosted its position in shares of CVS Health by 3.7% in the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator’s stock valued at $256,000 after acquiring an additional 204 shares during the period.

Rogco LP increased its holdings in CVS Health by 3.2% during the 4th quarter. Rogco LP now owns 6,752 shares of the pharmacy operator’s stock worth $303,000 after acquiring an additional 210 shares during the period.

Finally, Cozad Asset Management Inc. lifted its stake in CVS Health by 3.7% in the 4th quarter.

Cozad Asset Management Inc. now owns 6,532 shares of the pharmacy operator’s stock worth $293,000 after purchasing an additional 233 shares in the last quarter. 80.

66% of the stock is owned by institutional investors. Wall Street Analysts Forecast Growth Several research firms have recently weighed in on CVS. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th.

Argus set a $77.00 price target on CVS Health in a report on Tuesday, February 18th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th.

StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Finally, Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $55.

00 to $75.00 in a research note on Thursday, February 13th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company.

According to MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $70.39.

CVS Health Stock Down 5.9 % Shares of NYSE CVS opened at $63.54 on Monday.

The company has a market cap of $80.11 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 0.

98 and a beta of 0.57. The company has a quick ratio of 0.

60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

The firm’s fifty day moving average is $63.47 and its 200 day moving average is $58.01.

CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $74.

85. CVS Health ( NYSE:CVS – Get Free Report ) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.

19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30.

CVS Health had a net margin of 1.24% and a return on equity of 9.11%.

On average, equities research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share.

The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.

19%. CVS Health’s dividend payout ratio (DPR) is presently 72.68%.

Insider Activity at CVS Health In other CVS Health news, SVP James David Clark sold 7,513 shares of the company’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.

55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90.

This represents a 47.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website .

Also, Director Michael F. Mahoney bought 30,000 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were bought at an average cost of $66.

70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.

20. This represents a 320.65 % increase in their position.

The disclosure for this purchase can be found here . 0.24% of the stock is owned by corporate insiders.

CVS Health Company Profile ( Free Report ) CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles Five stocks we like better than CVS Health Financial Services Stocks Investing Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? Should You Add These Warren Buffett Stocks to Your Portfolio? Disney 2025 Shareholders: Major Updates for Investors Top Biotech Stocks: Exploring Innovation Opportunities Advance Auto Parts Stock: A Classic Rebound Play in the Making Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. ( NYSE:CVS – Free Report ).

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter ..